Logo image of BSX

BOSTON SCIENTIFIC CORP (BSX) Stock Price, Quote, News and Overview

NYSE:BSX - New York Stock Exchange, Inc. - US1011371077 - Common Stock - Currency: USD

106.54  -0.12 (-0.11%)

After market: 105.673 -0.87 (-0.81%)

BSX Quote, Performance and Key Statistics

BOSTON SCIENTIFIC CORP

NYSE:BSX (5/20/2025, 7:34:44 PM)

After market: 105.673 -0.87 (-0.81%)

106.54

-0.12 (-0.11%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High107.17
52 Week Low71.88
Market Cap157.58B
Shares1.48B
Float1.47B
Yearly Dividend0
Dividend YieldN/A
PE39.46
Fwd PE32.05
Earnings (Next)07-22 2025-07-22/bmo
IPO05-19 1992-05-19


BSX short term performance overview.The bars show the price performance of BSX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15

BSX long term performance overview.The bars show the price performance of BSX in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of BSX is 106.54 USD. In the past month the price increased by 12.09%. In the past year, price increased by 40.87%.

BOSTON SCIENTIFIC CORP / BSX Daily stock chart

BSX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.28 234.48B
ISRG INTUITIVE SURGICAL INC 72.93 199.70B
SYK STRYKER CORP 31.09 148.69B
MDT MEDTRONIC PLC 16.17 110.77B
BDX BECTON DICKINSON AND CO 12.54 50.73B
EW EDWARDS LIFESCIENCES CORP 29.93 45.76B
IDXX IDEXX LABORATORIES INC 45.36 41.91B
RMD RESMED INC 27.33 36.38B
DXCM DEXCOM INC 52.93 34.25B
GEHC GE HEALTHCARE TECHNOLOGY 15.62 32.90B
STE STERIS PLC 26.82 24.61B
PODD INSULET CORP 90.71 23.04B

About BSX

Company Profile

BSX logo image Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 53,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Company Info

BOSTON SCIENTIFIC CORP

300 Boston Scientific Way

Marlborough MASSACHUSETTS 01752 US

CEO: Michael F. Mahoney

Employees: 53000

BSX Company Website

BSX Investor Relations

Phone: 15086834000

BOSTON SCIENTIFIC CORP / BSX FAQ

What is the stock price of BOSTON SCIENTIFIC CORP today?

The current stock price of BSX is 106.54 USD. The price decreased by -0.11% in the last trading session.


What is the ticker symbol for BOSTON SCIENTIFIC CORP stock?

The exchange symbol of BOSTON SCIENTIFIC CORP is BSX and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is BSX stock listed?

BSX stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for BOSTON SCIENTIFIC CORP stock?

38 analysts have analysed BSX and the average price target is 120.09 USD. This implies a price increase of 12.72% is expected in the next year compared to the current price of 106.54. Check the BOSTON SCIENTIFIC CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BOSTON SCIENTIFIC CORP worth?

BOSTON SCIENTIFIC CORP (BSX) has a market capitalization of 157.58B USD. This makes BSX a Large Cap stock.


How many employees does BOSTON SCIENTIFIC CORP have?

BOSTON SCIENTIFIC CORP (BSX) currently has 53000 employees.


What are the support and resistance levels for BOSTON SCIENTIFIC CORP (BSX) stock?

BOSTON SCIENTIFIC CORP (BSX) has a support level at 106.18 and a resistance level at 106.55. Check the full technical report for a detailed analysis of BSX support and resistance levels.


Is BOSTON SCIENTIFIC CORP (BSX) expected to grow?

The Revenue of BOSTON SCIENTIFIC CORP (BSX) is expected to grow by 17.42% in the next year. Check the estimates tab for more information on the BSX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BOSTON SCIENTIFIC CORP (BSX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BOSTON SCIENTIFIC CORP (BSX) stock pay dividends?

BSX does not pay a dividend.


When does BOSTON SCIENTIFIC CORP (BSX) report earnings?

BOSTON SCIENTIFIC CORP (BSX) will report earnings on 2025-07-22, before the market open.


What is the Price/Earnings (PE) ratio of BOSTON SCIENTIFIC CORP (BSX)?

The PE ratio for BOSTON SCIENTIFIC CORP (BSX) is 39.46. This is based on the reported non-GAAP earnings per share of 2.7 and the current share price of 106.54 USD. Check the full fundamental report for a full analysis of the valuation metrics for BSX.


What is the Short Interest ratio of BOSTON SCIENTIFIC CORP (BSX) stock?

The outstanding short interest for BOSTON SCIENTIFIC CORP (BSX) is 1.07% of its float. Check the ownership tab for more information on the BSX short interest.


BSX Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to BSX. When comparing the yearly performance of all stocks, BSX is one of the better performing stocks in the market, outperforming 89.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BSX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to BSX. BSX scores excellent on profitability, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BSX Financial Highlights

Over the last trailing twelve months BSX reported a non-GAAP Earnings per Share(EPS) of 2.7. The EPS increased by 26.17% compared to the year before.


Industry RankSector Rank
PM (TTM) 11.58%
ROA 5.06%
ROE 9.15%
Debt/Equity 0.47
Chartmill High Growth Momentum
EPS Q2Q%33.93%
Sales Q2Q%20.93%
EPS 1Y (TTM)26.17%
Revenue 1Y (TTM)19.35%

BSX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to BSX. The Buy consensus is the average rating of analysts ratings from 38 analysts.

For the next year, analysts expect an EPS growth of 17.26% and a revenue growth 17.42% for BSX


Ownership
Inst Owners93.1%
Ins Owners0.18%
Short Float %1.07%
Short Ratio1.81
Analysts
Analysts83.68
Price Target120.09 (12.72%)
EPS Next Y17.26%
Revenue Next Year17.42%